Prostate Cancer

Innovative Procedure Minimizes Potential Prostate Cancer Radiation Side Effects

January 15th 2021, 9:30pm


Florida Cancer Specialists has integrated SpaceOAR Hydrogel into its armamentarium as a pre-treatment for radiation therapy in prostate cancer patients.

What Is Clinical Utility in a Tumor Biomarker Test? Former ASCO President Knows It When He Sees It

January 9th 2021, 9:15pm


Daniel F. Hayes, MD, offers definitions and an algorithm for clinicians to define clinical utility.

Huge Prostate Cancer Genetics Study Highlights Disparities in Risk, Research

January 9th 2021, 2:52am


The findings could lead to a precision medicine approach to prostate cancer screening.

Dr Neeraj Agarwal on Knowledge Gaps and Genomic Testing in Prostate Cancer

December 31st 2020, 1:00pm


Neeraj Agarwal, MD, University of Utah Huntsman Cancer Institute, discusses knowledge gaps and the importance of genomic testing in prostate cancer.

Dr Neeraj Agarwal on Who Can Benefit from PARP Inhibition

December 24th 2020, 3:00pm


Neeraj Agarwal, MD, University of Utah Huntsman Cancer Institute, shares his experience regarding the prostate cancer patients who could potentially benefit from PARP inhibition.

What We’re Reading: Congress Delays Start of RO Model; Examining Novel COVID-19 Strain; Pandemic Death Rates

December 22nd 2020, 3:26pm


Congress passes legislation that will delay the start of the Radiation Oncology (RO) Advanced Payment Model; examining the newly identified variant of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19); a study finds Hispanics and those without college degrees most subject to excess death during pandemic.

What We’re Reading: Genomic Indicators Predict Prostate Cancer Outcomes; FDA Authorizes At-Home COVID-19 Test; Herd Immunity Possible by Spring 2021

December 16th 2020, 2:54pm


Samples show certain subgroups of men with prostate cancer are more receptive to radiation therapy; FDA grants emergency use authorization to an at-home coronavirus disease 2019 (COVID-19) test; Anthony Fauci, MD, says COVID-19 herd immunity is possible by spring 2021.

Dr Neeraj Agarwal on PARP Inhibitor Combination Treatments for Prostate Cancer

December 15th 2020, 9:00pm


Neeraj Agarwal, MD, a clinician and researcher at the University of Utah Huntsman Cancer Institute, discusses investigational combinations with PARP inhibitors in prostate cancer treatment.

Research Finds 2 New Targets for Prostate Cancer Therapies

December 12th 2020, 4:00pm


The genes are part of the family that cause cancer cells to grow.

Dr Neeraj Agarwal Discusses PARP Inhibitors as First-Line Prostate Cancer Treatment

December 11th 2020, 3:30pm


Neeraj Agarwal, MD, of the University of Utah's Huntsman Cancer Institute, discusses ongoing trials of PARP inhibitors as first-line metastatic prostate cancer treatments.